In domo » Solution

Solution

Specifica antibody
2024-04-11
Client Case: Development of a Roman Antibody medicamento targeting II-XXV ad atopic DERMATITIS (AD), A PHARMACEUTICAL Developing New Anti-XXV Anti-
Read More
Parvus Moleculars
2024-04-11
Client No.1: Efficaciam novel compositis in EAE Model Client Background: noster client est pharmaceutical comitatu quod developed a nove compositis disposito ad target mitochondricus damnum actis autophagy et possidet neurroregenrater proprietatibus. Et Client aims ut explorarent potentiale medicinales
Read More

HKEYBIO est contractus Research Organization (CRO) specialiter in preclinical investigationis in agro autoimmune morbo.

Quick Links

Tel: + 86-512-67485716

Phone: LXXXVI - 18051764581

== I ==
Add: Building B, No.388 Xingping Street, ascendas Ihub Suzhou Industrial Park, Jiangsu, Sina

Relinquere nuntium

Subscribo

Subscribere sursum pro nostra Newsletter ad recipere tardus nuntium.